References
- International Diabetes Federation. Diabetes Atlas (3rd Edition). Brussels, Belgium (2006).
- Woodward M, Zhang X, Barzi F et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia–Pacific region. Diabetes Care26, 360–366 (2003).
- Adler AI, Stevens RJ, Manley SE et al. Development and progression of nephropathy in Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int.63(1), 225–232 (2003).
- Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ321(7258), 405–412 (2000).
- HOPE (Heart Outcomes Prevention Evaluation) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med.342, 145–153 (2000).
- Tuomilehto J, Rastenyte D, Birkenhager WH et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N. Engl. J. Med.340(9), 677–684 (1999).
- Kloner RA, Neutel J, Roth EM et al. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the amlodipine diabetic hypertension efficacy response evaluation trial. Ann. Pharmacother.42(11), 1552–1562 (2008).
- United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ317, 703–713 (1998).
- Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet351, 1755–1762 (1998).
- Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet355, 253–258 (2000).
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet352, 837–853 (1998).
- ADVANCE Collaborative Group. Study rationale and design of ADVANCE: action in diabetes and vascular disease – preterax and Diamicron MR controlled evaluation. Diabetologia44(9), 1118–1120 (2001).
- ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with Type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet370(9590), 829–840 (2007).
- The Advance Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med.358(24), 2560–2572 (2008).
- Chalmers J, Joshi R, Kengne AP et al. Efficacy and safety of fixed combination of perindopril and indapamide in Type 2 diabetes: results from ADVANCE in context of available evidence. J. Hypertens.26(Suppl. 3), S21–S27 (2008).
- Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet362(9395), 1527–1535 (2003).
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med.358(24), 2545–2559 (2008).
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in Type 2 diabetes. N. Engl. J. Med.359(15), 1577–1589 (2008).
- Chalmers J, Cooper ME. UKPDS and the legacy effect. NEJM359(15), 1618–1620 (2008).
- Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with Type 2 diabetes. N. Engl. J. Med.360, 129–139 (2009).
- Holman RR, Paul SK, Bethel MA, Neil HAW, Matthews DR. Long-term follow-up after tight control of blood pressure in Type 2 diabetes. N. Engl. J. Med.359(15), 1565–1576 (2008).